Subscribe Become an Author Sign Up Log In

Molomics

Company
Founded
2015
Status
Private
Geography
Spain based

About

Molomics advances the search for structurally novel small molecule therapeutics by Artificial Intelligence (AI) through integrating it with Human Collective Intelligence (HCI). As molecules are designed collaboratively in silico between machine and humans, we expect that our drug candidates are more efficacious and safer, increasing the success rates in clinical development.

Business model
  • Operations Service
Therapeutic focus
  • Neuroscience
Data type used for modelling
  • HTS and HCS data
  • Network biology analysis (omics)
Drug Discovery Strategy
  • Structure Based Drug Discovery (SBDD)
Product type
  • Small molecules
Research focus
  • Preclinical Development